SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hakan Gulmez, Yigit Akin, Murat Savas, Mehmet Gulum, Halil Ciftci, Soner Yalcinkaya, Ercan Yeni, Impact of Iron Supplementation on Sexual Dysfunction of Women with Iron Deficiency Anemia in Short Term: A Preliminary Study, The Journal of Sexual Medicine, 2014, 11, 4
  2. 2
    Daniel Limi Cacic, Tor Hervig, Jerard Seghatchian, Anemia treatment of lymphoproliferative malignancies with erypoiesis: An overview of state of the art, Transfusion and Apheresis Science, 2013, 48, 2, 277

    CrossRef

  3. 3
    Elaine Boland, Christine Eiser, Yousef Ezaydi, Diana M. Greenfield, Sam H. Ahmedzai, John A. Snowden, Living With Advanced But Stable Multiple Myeloma: A Study of the Symptom Burden and Cumulative Effects of Disease and Intensive (Hematopoietic Stem Cell Transplant-Based) Treatment on Health-Related Quality of Life, Journal of Pain and Symptom Management, 2013, 46, 5, 671

    CrossRef

  4. You have free access to this content4
    Mauricette Michallet, Karine Goldet, Mohamad Sobh, Stéphane Morisset, Youcef Chelghoum, Xavier Thomas, Fiorenza Barraco, Sophie Ducastelle, Hélène Labussière, Catherine Renzullo, Carole Paillet, Christine Pivot, Perrine Badol-Van Straaten, Angelique Denis, Anne Termoz, Marie Detrait, Franck-Emmanuel Nicolini, Isabelle Jaisson-Hot, Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients, Cancer, 2013, 119, 1
  5. 5
    Maria E. Cabanillas, Hagop Kantarjian, Deborah A. Thomas, Gloria N. Mattiuzzi, Michael E. Rytting, Eduardo Bruera, Lianchun Xiao, B. Nebiyou Bekele, Maria C. Foudray, Jorge E. Cortes, Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma, Cancer, 2012, 118, 3
  6. 6
    M. Aapro, J. Rüffer, S. Fruehauf, Haematological support, fatigue and elderly patients, Journal of Geriatric Oncology, 2012, 3, 3, 246

    CrossRef

  7. 7
    Jean-Luc Canon, Johan Vansteenkiste, Michael Hedenus, Pere Gascon, Carsten Bokemeyer, Heinz Ludwig, Jan Vermorken, Jason Legg, Beatriz Pujol, Ken Bridges, Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥10 g/dL: an exploratory analysis of a phase 3 trial, Medical Oncology, 2012, 29, 3, 2291

    CrossRef

  8. 8
    Valeria Santini, Treatment of Low-Risk Myelodysplastic Syndrome: Hematopoietic Growth Factors Erythropoietins and Thrombopoietins, Seminars in Hematology, 2012, 49, 4, 295

    CrossRef

  9. 9
    Isabelle Wauters, Johan Vansteenkiste, Erythropoiesis-stimulating agents in cancer patients: reflections on safety, Expert Review of Clinical Pharmacology, 2011, 4, 4, 467

    CrossRef

  10. 10
    Alex Molassiotis, Barbara Wilson, Susan Blair, Tracy Howe, James Cavet, Living with multiple myeloma: experiences of patients and their informal caregivers, Supportive Care in Cancer, 2011, 19, 1, 101

    CrossRef

  11. 11
    J. D. Rizzo, M. Brouwers, P. Hurley, J. Seidenfeld, M. O. Arcasoy, J. L. Spivak, C. L. Bennett, J. Bohlius, D. Evanchuk, M. J. Goode, A. A. Jakubowski, D. H. Regan, M. R. Somerfield, American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer, Blood, 2010, 116, 20, 4045

    CrossRef

  12. 12
    François Lüthi, Miklos Pless, Serge Leyvraz, Beat Biedermann, Emilie Müller, Richard Hermann, Christian Monnerat, Dose reduction of epoetin-alpha in the prevention of chemotherapy-induced anaemia, Supportive Care in Cancer, 2010, 18, 12, 1515

    CrossRef

  13. 13
    Hikmat Abdel-Razeq, Shadi Hijjawi, Hazem Abdulelah, Rula Amarin, Majid Asawaeer, Haitham Shaheen, The impact of recently published negative erythropoiesis-stimulating agent studies on the clinical management of cancer-related anemia at a single center, Hematology/Oncology and Stem Cell Therapy, 2010, 3, 2, 78

    CrossRef

  14. 14
    Ann Kristin Kvam, Peter Fayers, Marianne Hjermstad, Nina Gulbrandsen, Finn Wisloff, Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations, European Journal of Haematology, 2009, 83, 4
  15. 15
    Eirini Katodritou, Meletios A. Dimopoulos, Konstantinos Zervas, Evangelos Terpos, Update on the use of erythropoiesis-stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphoma, Cancer Treatment Reviews, 2009, 35, 8, 738

    CrossRef

  16. 16
    P.F.W. Strengers, E. van Twuijver, 2009,

    CrossRef

  17. 17
    Javier de Castro, Cristóbal Belda-Iniesta, Dolores Isla, Manuel Dómine, Alfredo Sánchez, Eduard Batiste, Manuel González Barón, Early intervention with epoetin beta prevents severe anaemia in lung cancer patients receiving platinum-based chemotherapy: A subgroup analysis of the NeoPrevent study, Lung Cancer, 2008, 59, 2, 211

    CrossRef

  18. 18
    J.H. Schouwink, H. Codrington, H.P. Sleeboom, L.G.M. Kerkhofs, L.W. Wormhoudt, Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy, European Journal of Cancer, 2008, 44, 6, 819

    CrossRef

  19. 19
    I. Ray-Coquard, D. Kassab-Chahmi, N. Casadevall, P. Chastagner, C. Marchal, P. Marec-Bérard, J. -L. Misset, Standards, Options: Recommandations pour I’indication des agents stimulant l’érythropoïèse (ASE: époétine alpha, époétine bêta et darbépoétine) dans la prise en charge de l’anémie en cancérologie (mise à jour 2007), rapport abrégé, Oncologie, 2008, 10, 2, 160

    CrossRef

  20. 20
    Nadine Shehata, Irwin Walker, Ralph Meyer, Adam E Haynes, Kevin Imrie, The use of erythropoiesis-stimulating agents in patients with non-myeloid hematological malignancies: a systematic review, Annals of Hematology, 2008, 87, 12, 961

    CrossRef

  21. 21
    J. D. Rizzo, M. R. Somerfield, K. L. Hagerty, J. Seidenfeld, J. Bohlius, C. L. Bennett, D. F. Cella, B. Djulbegovic, M. J. Goode, A. A. Jakubowski, M. U. Rarick, D. H. Regan, A. E. Lichtin, Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update, Blood, 2008, 111, 1, 25

    CrossRef

  22. 22
    Heather S Jim, Paul B Jacobsen, Cancer Supportive Care: Advances in Therapeutic Strategies, 2008,

    CrossRef

  23. 23
    Jeffrey Crawford, Francisco Robert, Michael C. Perry, Chandra Belani, Denise Williams, A Randomized Trial Comparing Immediate versus Delayed Treatment of Anemia with Once-Weekly Epoetin Alfa in Patients with Non-small Cell Lung Cancer Scheduled to Receive First-Line Chemotherapy, Journal of Thoracic Oncology, 2007, 2, 3, 210

    CrossRef

  24. 24
    Frank J Papatheofanis, Comparative costs of treatment with epoetin alfa and darbepoetin alfa for anemia in the oncology and nephrology settings, Expert Review of Pharmacoeconomics & Outcomes Research, 2007, 7, 1, 59

    CrossRef

  25. 25
    Giacomo Cartenì, Laura Giannetta, Giovanni Ucci, Giorgio De Signoribus, Aldo Vecchione, Graziella Pinotti, Fabio Puglisi, Antonio Contillo, Giuseppe Pezzella, Simona Orecchia, Patrizia Beccaglia, Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly, Supportive Care in Cancer, 2007, 15, 9, 1057

    CrossRef

  26. 26
    David H. Henry, Epoetin Alfa Treatment for Patients with Chemotherapy-Induced Anemia, Supportive Cancer Therapy, 2007, 4, 2, 78

    CrossRef

  27. 27
    Gunnar Birgegård, Epoetin treatment in haematologic malignancy: How to improve response?, European Journal of Cancer Supplements, 2007, 5, 5, 436

    CrossRef

  28. 28
    David H Henry, Guidelines and Recommendations for the Management of Anaemia in Patients with Lymphoid Malignancies, Drugs, 2007, 67, 2, 175

    CrossRef

  29. 29
    Ruben A. Mesa, Joyce Niblack, Martha Wadleigh, Srdan Verstovsek, John Camoriano, Sunni Barnes, Angelina D. Tan, Pamela J. Atherton, Jeff A. Sloan, Ayalew Tefferi, The burden of fatigue and quality of life in myeloproliferative disorders (MPDs), Cancer, 2007, 109, 1
  30. 30
    Tim Littlewood, Jean-Jacques Zambrowski, Paul Cornes, Treating anaemia: deconstructing healthcare costs, Current Medical Research and Opinion, 2006, 22, s4, S23

    CrossRef

  31. 31
    Thomy Tonia, Annette Mettler, Nadège Robert, Guido Schwarzer, Jerome Seidenfeld, Olaf Weingart, Chris Hyde, Andreas Engert, Julia Bohlius, Erythropoietin or darbepoetin for patients with cancer, The Cochrane Library,
  32. 32
    Julia Bohlius, Kurt Schmidlin, Corinne Brillant, Guido Schwarzer, Sven Trelle, Jerome Seidenfeld, Marcel Zwahlen, Mike J Clarke, Olaf Weingart, Sabine Kluge, Margaret Piper, Maryann Napoli, Dirk Rades, David Steensma, Benjamin Djulbegovic, Martin F Fey, Isabelle Ray-Coquard, Volker Moebus, Gillian Thomas, Michael Untch, Martin Schumacher, Matthias Egger, Andreas Engert, Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data, The Cochrane Library,